Foresite Capital Management IV, LLC
WEST HOLLYWOOD CA · SEC CIK 0001704132
$2.90亿2026Q2 申报市值
6持仓数
100.0%前十大占比 · 第一大 57.0%
1 / 3新建仓 / 清仓
26Q126Q2
前十大持仓 占组合比例
2026Q2 买入最多 按季末市值估算
CYTK 加仓+$1,800.92万
Crinetics Pharma 新建仓+$561.30万
RLAY 加仓+$467.75万
2026Q2 卖出最多 按季末市值估算
LYEL 清仓-$1,605.60万
ALEC 清仓-$835.75万
MAZE 清仓-$468.35万
2026Q2 持仓明细 点表头排序
导出 CSV 🔒| 代码 | 名称 | 市值 ▼ | 占比 | 股数 | 变动股数 | 变动 | 估算买卖额 | 操作 |
|---|---|---|---|---|---|---|---|---|
| PHVS | Pharvaris N.V. | $1.65亿 | 56.95% | 4,778,581 | 0 | 0.0% | — | 不变 |
| CYTK | CYTOKINETICS INC | $6,088.49万 | 20.98% | 714,695 | 211,400 | 42.0% | $1,800.92万 | 加仓 |
| EIKN | Eikon Therapeutics, Inc. | $2,536.51万 | 8.74% | 1,943,682 | 0 | 0.0% | — | 不变 |
| RLAY | Relay Therapeutics, Inc. | $2,338.75万 | 8.06% | 1,250,000 | 250,000 | 25.0% | $467.75万 | 加仓 |
| XENE | Xenon Pharmaceuticals Inc. | $965.76万 | 3.33% | 160,000 | 0 | 0.0% | — | 不变 |
| — | Crinetics Pharmaceuticals, Inc. | $561.30万 | 1.93% | 150,000 | 150,000 | — | $561.30万 | 新建仓 |
| LYEL | Lyell Immunopharma, Inc. | $0 | 0.00% | 0 | -800,399 | -100.0% | -$1,605.60万 | 清仓 |
| ALEC | Alector, Inc. | $0 | 0.00% | 0 | -3,887,200 | -100.0% | -$835.75万 | 清仓 |
| MAZE | Maze Therapeutics, Inc. | $0 | 0.00% | 0 | -156,901 | -100.0% | -$468.35万 | 清仓 |